A Study on the Efficacy and Safety of Sintilimab Combined with Bevacizumab in Perioperative Neoadjuvant Chemotherapy for Locally Advanced Low Rectal Cancer
Latest Information Update: 10 Feb 2025
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary) ; Oxaliplatin (Primary) ; Sintilimab (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
Most Recent Events
- 10 Feb 2025 New trial record